Prescription drug middlemen are shifting away from rebates to increasingly large...
A new CDC study highlights just how violent the recent past has been in the U.S....
What happened to the market for monkeys? Are some drugs too cheap? And why are b...
The FDA has released a new plan allowing developers of medical devices that rely...
A federal judge Thursday reversed a major Obamacare provision requiring plans to...
The FDA approved selling Narcan without a prescription, setting the overdose-rev...
Mathai Mammen, who until recently led research at Johnson & Johnson, will become...
The U.S.'s usual, reactive approach to disease — wait for it to spring up before...
Is there $21 billion left for Covid response, or $5 billion? The White House’s f...
Lisa Barnes runs one of the nation’s largest studies of Alzheimer’s disease focu...
In a rare move, the Dutch health ministry refused to provide coverage for a Gile...
The NIH has released data showing more clinical trial sponsors are reporting res...
Just three lupus drugs have been approved by the FDA in six decades. A new partn...
The Marburg outbreak in Equatorial Guinea continues to grow, the WHO said, as th...
New research from a CRISPR pioneer offers a potential solution to delivery chall...
In the first two months of this year, 15% of 16,000 Ozempic dispenses in British...
